• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往治疗史及其对犯罪再犯的影响。

Prior treatment history and its impact on criminal recidivism.

作者信息

Merrill J, Alterman A, Cacciola J, Rutherford M

机构信息

Treatment Research Institute, University of Pennsylvania School of Medicine, Philadelphia 19103, USA.

出版信息

J Subst Abuse Treat. 1999 Dec;17(4):313-9. doi: 10.1016/s0740-5472(99)00012-4.

DOI:10.1016/s0740-5472(99)00012-4
PMID:10587933
Abstract

This study examines the hypothesis that treatment is a cumulative process; that is, treatment success is best viewed in terms of the patient's entire treatment history, rather than the index treatment episode. Three-hundred and eight patients with a primary heroin addiction were studied for 2 years posttreatment. Using posttreatment arrests as the dependent variable, the effects of prior treatment were assessed. Those with six or more prior treatment episodes and who had been in treatment for 12 or more months during the most recent episode averaged only 0.2 arrests in the 2 years posttreatment, while those with no prior treatment, but 12 or more months in the recent treatment averaged 0.88 arrests. Logistic analysis found that each prior treatment reduced the probability of a posttreatment arrest by 25%. Based on a linear regression, patients with six or more treatments prior treatments averaged half the number of posttreatment arrests as someone with no treatments before the index episode.

摘要

本研究检验了治疗是一个累积过程的假设;也就是说,治疗成功最好从患者的整个治疗史角度来看待,而不是从本次治疗发作来看。对308名原发性海洛因成瘾患者进行了治疗后2年的研究。以治疗后的逮捕情况作为因变量,评估先前治疗的效果。那些有6次或更多先前治疗发作且在最近一次发作期间接受治疗12个月或更长时间的患者,在治疗后2年平均只有0.2次被捕,而那些没有先前治疗但最近治疗12个月或更长时间的患者平均有0.88次被捕。逻辑分析发现,每次先前治疗会使治疗后被捕的概率降低25%。基于线性回归,有6次或更多先前治疗的患者治疗后被捕的平均次数是在本次发作前没有治疗的患者的一半。

相似文献

1
Prior treatment history and its impact on criminal recidivism.既往治疗史及其对犯罪再犯的影响。
J Subst Abuse Treat. 1999 Dec;17(4):313-9. doi: 10.1016/s0740-5472(99)00012-4.
2
Revisiting the effectiveness of methadone treatment on crime reductions in the 1990s.重新审视20世纪90年代美沙酮治疗对减少犯罪的有效性。
J Subst Abuse Treat. 1999 Jun;16(4):329-35. doi: 10.1016/s0740-5472(98)00050-6.
3
The onset of heroin use and criminal behaviour: does order make a difference?海洛因使用与犯罪行为的起始:顺序有影响吗?
Drug Alcohol Depend. 1998 Dec 1;53(1):79-86. doi: 10.1016/s0376-8716(98)00107-0.
4
Recovery from opioid addiction in DATOS.数据辅助治疗中阿片类药物成瘾的康复情况。
J Subst Abuse Treat. 2003 Oct;25(3):177-86. doi: 10.1016/s0740-5472(03)00125-9.
5
Treatment retention and outcome among cocaine-dependent patients with and without active criminal justice involvement.有和没有积极刑事司法介入的可卡因依赖患者的治疗保留率和治疗结果。
J Am Acad Psychiatry Law. 2007;35(1):83-91.
6
Followup of cocaine-dependent men and women with antisocial personality disorder.对患有反社会人格障碍的可卡因依赖男性和女性的随访。
J Subst Abuse Treat. 2003 Oct;25(3):155-64. doi: 10.1016/s0740-5472(03)00127-2.
7
A randomized controlled trial of interim methadone maintenance.美沙酮维持治疗中期的一项随机对照试验。
Arch Gen Psychiatry. 2006 Jan;63(1):102-9. doi: 10.1001/archpsyc.63.1.102.
8
Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence.反社会人格障碍作为可卡因依赖药物治疗的一个预后因素。
Drug Alcohol Depend. 1994 Mar;35(1):31-5. doi: 10.1016/0376-8716(94)90107-4.
9
Explaining the effectiveness of heroin-assisted treatment on crime reductions.解释海洛因辅助治疗对减少犯罪的有效性。
Law Hum Behav. 2009 Feb;33(1):83-95. doi: 10.1007/s10979-008-9138-8. Epub 2008 Jul 2.
10
What happens when contingency management treatment ends? A tale of two clients.应急管理治疗结束后会发生什么?两个客户的故事。
Am J Addict. 2008 May-Jun;17(3):241-4. doi: 10.1080/10550490802019923.

引用本文的文献

1
Attitudes and practices regarding the use of methadone in US state and federal prisons.美国州立和联邦监狱中使用美沙酮的态度与做法。
J Urban Health. 2005 Sep;82(3):411-9. doi: 10.1093/jurban/jti072. Epub 2005 May 25.